MG
Meditor Group Portfolio holdings
AUM
$48.1M
This Quarter Return
+6.19%
1 Year Return
+38.67%
3 Year Return
+41.15%
5 Year Return
+72.2%
10 Year Return
+1,065.64%
AUM
$738M
AUM Growth
–
Cap. Flow
+$738M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
70.61%
Holding
40
New
40
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Merck
MRK
|
$86.7M |
| 2 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
$83.5M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$76.9M |
| 4 |
Exelixis
EXEL
|
$54.5M |
| 5 |
VVUS
Vivus Inc
VVUS
|
$52.9M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 43.01% |
| 2 | Technology | 12.4% |
| 3 | Communication Services | 11.96% |
| 4 | Financials | 5.33% |
| 5 | Consumer Staples | 2.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Merck
MRK
$210B
| $86.7M | 11.74% | +1,866,600 | New | +$86.7M |
|
|
ONXX
2
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
| $83.5M | 11.31% | +962,103 | New | +$83.5M |
|
|
3
Alphabet (Google) Class C
GOOG
$2.58T
| $76.9M | 10.41% | +87,300 | New | +$76.9M |
|
|
4
Exelixis
EXEL
$10.1B
| $54.5M | 7.38% | +12,000,000 | New | +$54.5M |
|
|
VVUS
5
DELISTED
Vivus Inc
VVUS
| $52.9M | 7.17% | +4,207,296 | New | +$52.9M |
|
6
Alkermes
ALKS
$4.78B
| $48.8M | 6.6% | +1,700,000 | New | +$48.8M |
|
7
HP
HPQ
$26.7B
| $41.6M | 5.63% | +1,676,423 | New | +$41.6M |
|
|
NYX
8
DELISTED
NYSE EURONEXT INC
NYX
| $32.1M | 4.35% | +776,070 | New | +$32.1M |
|
9
BlackBerry
BB
$2.28B
| $23.1M | 3.13% | +2,210,000 | New | +$23.1M |
|
|
SFD
10
DELISTED
SMITHFIELD FOODS,INC
SFD
| $21.3M | 2.89% | +651,000 | New | +$21.3M |
|
|
URS
11
DELISTED
URS CORP
URS
| $17M | 2.3% | +360,000 | New | +$17M |
|
12
Nektar Therapeutics
NKTR
$568M
| $16.7M | 2.27% | +1,450,000 | New | +$16.7M |
|
13
Apple
AAPL
$3.45T
| $16.3M | 2.2% | +41,000 | New | +$16.3M |
|
|
LIFE
14
DELISTED
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
| $16.1M | 2.17% | +217,000 | New | +$16.1M |
|
15
Ionis Pharmaceuticals
IONS
$6.79B
| $14M | 1.89% | +520,000 | New | +$14M |
|
|
BKS
16
DELISTED
Barnes & Noble
BKS
| $14M | 1.89% | +875,000 | New | +$14M |
|
|
ITMN
17
DELISTED
INTERMUNE INC
ITMN
| $13.2M | 1.79% | +1,375,000 | New | +$13.2M |
|
18
Liberty Global Class C
LBTYK
$4.07B
| $11.5M | 1.56% | +169,254 | New | +$11.5M |
|
|
WCRX
19
DELISTED
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
| $11.3M | 1.53% | +566,000 | New | +$11.3M |
|
|
OREX
20
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $11.1M | 1.5% | +1,900,000 | New | +$11.1M |
|
|
OPTR
21
DELISTED
OPTIMER PHARMACEUTICALS, INC. COM STK
OPTR
| $6.87M | 0.93% | +475,000 | New | +$6.87M |
|
22
Universal Health Services
UHS
$11.6B
| $6.7M | 0.91% | +100,000 | New | +$6.7M |
|
|
SHPG
23
DELISTED
Shire pic
SHPG
| $6.66M | 0.9% | +70,000 | New | +$6.66M |
|
|
BMC
24
DELISTED
BMC SOFTWARE, INC
BMC
| $6.63M | 0.9% | +147,000 | New | +$6.63M |
|
25
Alnylam Pharmaceuticals
ALNY
$58.5B
| $4.48M | 0.61% | +144,647 | New | +$4.48M |
|